Telisotuzumab vedotin-tllv
Full descriptor
Injection, telisotuzumab vedotin-tllv, 1 mg
Details
- Code
- J9326
- Short descriptor
- Telisotuzumab vedotin-tllv
- Code set
- HCPCS Level II
- Release
- July 2026
- Status
- Active
- Added
- Jan 1 2026
Nearby codes
Code sets are published in blocks, so neighbours are usually related.
Inj talimogene laherparepvec
Inj, pemrydi rtu, 10 mg
Temozolomide injection
Inj pemetrexed ditromethamin
Inj, tislelizumab-jsgr
Temsirolimus injection
Inj pemetrexed (bluepoint)
Inj epcoritamab-bysp 0.16 mg
Sources
- CMS HCPCS Level II — July 2026, public domain
Reference information only. Not billing advice. Verify against the payer before you file.